GlassScriptPhysician profile
James G Reid
NPI 1770594046
$382.75
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.50 · 2021: $283 · 2022: $61.82.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Qt Imaging, INC. | $146.65 | 2021 | |
| Checkpoint Surgical, INC | $136.78 | 2021 | |
| Gemini Mountain Medical, LLC | $31.93 | 2022 | |
| Smith+Nephew, INC. | $23.21 | 2019 | |
| Kci USA, INC. | $17.42 | 2022 | |
| Horizon Therapeutics Plc | $14.29 | 2019 | |
| Bioventus LLC | $12.47 | 2022 |
Research and ownership
$314,860.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Reid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.